Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats.
about
Adenosine receptors as therapeutic targetsAdenosine signaling and function in glial cellsPotential therapeutic interest of adenosine A2A receptors in psychiatric disorders.Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicityAdenosine A2A receptors modulate acute injury and neuroinflammation in brain ischemiaProduction of leukotrienes in a model of focal cerebral ischaemia in the ratCorrelation of transient adenosine release and oxygen changes in the caudate-putamen.Adenosine A(2A) receptors in early ischemic vascular injury after subarachnoid hemorrhage. Laboratory investigation.Parallel modification of adenosine extracellular metabolism and modulatory action in the hippocampus of aged rats.Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review.Regulation of foam cells by adenosine.Genetics of caffeine consumption and responses to caffeine.Adenosine and neurotrauma: therapeutic perspectives.Ionotropic receptors and ion channels in ischemic neuronal death and dysfunction.3-(Fur-2-yl)-10-(2-phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a novel adenosine receptor antagonist with A(2A)-mediated neuroprotective effects.Pathophysiological roles for purines: adenosine, caffeine and urate.Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slicesDARPP chocolate: a caffeinated morsel of striatal signaling.Binding of the prototypical adenosine A(2A) receptor agonist CGS 21680 to the cerebral cortex of adenosine A(1) and A(2A) receptor knockout mice.Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.Hypoxia-inducible factor 1 protects hypoxic astrocytes against glutamate toxicity.Adenosine, neurodegeneration and neuroprotection.The protective effect of adenosine A2A receptor antagonism in cerebral ischemia.The role of ATP and adenosine in the brain under normoxic and ischemic conditionsAdenosine kinase is a new therapeutic target to prevent ischemic neuronal death.Targets for neuroprotection in Parkinson's diseaseAdenosine 2A receptor: a crucial neuromodulator with bidirectional effect in neuroinflammation and brain injury.Genetic and pharmacological inactivation of adenosine A2A receptor reveals an Egr-2-mediated transcriptional regulatory network in the mouse striatum.How does adenosine control neuronal dysfunction and neurodegeneration?The role of HIFs in ischemia-reperfusion injury.Pathological overproduction: the bad side of adenosine.Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockadeAdenosine A2A receptor signaling regulation of cardiac NADPH oxidase activity.Nuclear Factor κB and Adenosine Receptors: Biochemical and Behavioral Profiling.Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes.Enhanced neuronal damage by co-administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists.Adenosine and stroke: maximizing the therapeutic potential of adenosine as a prophylactic and acute neuroprotectant.The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen-glucose deprivation in rat CA1 hippocampal slices.Intracerebral adenosine infusion improves neurological outcome after transient focal ischemia in rats.Cortical spreading depression-induced preconditioning in mouse neocortex is lamina specific.
P2860
Q24632095-11EDE08F-9B45-4D95-8548-12366549CE12Q24634273-E486C3A0-8CEB-41A7-B544-6AFBDF215147Q24657796-1BDBC396-90E5-443B-A1F0-FF8A0C179B40Q24672753-EA7DBD38-7FBB-47EF-8F5D-B70A60D46466Q26851322-6FB5FC12-163C-44F1-94E3-99A2CBCF872BQ28345776-27B065A9-6EDD-4EE1-ABB7-86C00A67E6ACQ30276561-172916B1-6319-407B-BC60-D59806F38AC9Q30434574-2913936A-3573-4377-A7C8-0F429BAB638EQ32034687-9FB9CC08-0F4F-4959-84E6-32F91A93CE94Q33971113-0BB077F8-249A-4B66-B10E-B78CAC8F83F7Q34031160-DE21D8C4-F75B-4E4C-AE99-78778E0EB752Q34119748-34FF5E84-663A-4FB1-8AF6-66FB58BDB4A4Q34230282-D778E450-1273-45B8-9FE7-F90D734350DFQ34292324-8BEEBFAA-0C78-4564-993B-DAFF198B3156Q34365007-3B5E2B06-69A4-4137-A5C7-3F58D7B84F99Q35008049-DE7EAB3F-922F-410E-9542-90508D0251C6Q35041668-79DB9DA2-78C6-4938-8157-D02EC1B14D23Q35044987-2703D238-7519-49D1-8A34-28596869177FQ35046240-8499A307-2C68-49FC-B744-B38BD8A11F17Q35489240-99FB51B7-5464-43C2-A7F0-2156ECCDDB61Q35998064-EDB448EE-995A-4C8A-A4CE-FC9FCAD373F7Q36097330-AB51A64F-A950-4F16-B7C8-3DC446249EF8Q36097335-E9F08362-FCD2-48C7-831A-87F22D28B88DQ36131077-C75136D2-CB0C-4D42-B472-F99051811763Q37206467-98076F14-3D0F-460B-9C1D-CB0768664151Q37302453-13C6F620-F32A-45D6-A990-B7E33D79EFD9Q37863150-3AD8328C-3E83-444D-B06C-0900E722BE67Q38323124-FD221FFC-FEA0-4003-AB58-60A8B3A29FF2Q38882782-2A54B269-D253-470D-930B-5AD6390953B6Q38989135-F3963EAD-9E08-4C32-A0FB-100AB385BE1FQ39157893-3ECA2522-03FA-4126-BE0B-03A0A1575585Q40722338-10D72B70-E6F1-40E1-93BC-210DB57D42FAQ41268608-BB6B1EA2-8312-48C2-8645-CBC384BF843EQ41767515-D0CBB105-3A4F-4D91-B2C7-3597079222CFQ41835487-1AF70181-0603-494E-BD25-5A82E2FE110FQ42065141-4A207819-2E84-43C1-98EB-48A20D05D281Q42594826-B78A0C34-BBCE-436D-8E27-CFD349453100Q43078271-9FD48BA1-2D51-4029-9136-0C2DAC068CB5Q43962255-E6603B93-D1F4-4B2D-A169-08DEDC18382BQ44662833-013D24ED-3238-458D-85FA-6C5B4D405170
P2860
Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats.
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
Blockade of adenosine A2A rece ...... in cerebral ischaemia in rats.
@ast
Blockade of adenosine A2A rece ...... in cerebral ischaemia in rats.
@en
Blockade of adenosine A2A rece ...... in cerebral ischaemia in rats.
@nl
type
label
Blockade of adenosine A2A rece ...... in cerebral ischaemia in rats.
@ast
Blockade of adenosine A2A rece ...... in cerebral ischaemia in rats.
@en
Blockade of adenosine A2A rece ...... in cerebral ischaemia in rats.
@nl
prefLabel
Blockade of adenosine A2A rece ...... in cerebral ischaemia in rats.
@ast
Blockade of adenosine A2A rece ...... in cerebral ischaemia in rats.
@en
Blockade of adenosine A2A rece ...... in cerebral ischaemia in rats.
@nl
P2093
P1433
P1476
Blockade of adenosine A2A rece ...... in cerebral ischaemia in rats.
@en
P2093
P304
P356
10.1097/00001756-199812010-00034
P577
1998-12-01T00:00:00Z